SARS-CoV-2 Lambda Variant: The New Kid on the Block

By vgn1 | July 19, 2021 | Comments Off on SARS-CoV-2 Lambda Variant: The New Kid on the Block

SARS-CoV-2 Lambda Variant: The New Kid on the Block July 19, 2021 The COVID-19 pandemic has been marked by the ongoing emergence of new genetic variants. Although SARS-CoV-2 is an RNA virus, its genome is relative stable, thanks to a proofreading polymerase. However, in a situation with extensive viral transmission globally, the evolution of SARS-CoV-2…

Read More

Global Virus Network (GVN) Adds Senegal’s IRESSEF As Newest Member to Mitigate Viral Threats

By vgn1 | July 15, 2021 | Comments Off on Global Virus Network (GVN) Adds Senegal’s IRESSEF As Newest Member to Mitigate Viral Threats

Baltimore, Maryland, USA, July 15, 2021: The Global Virus Network (GVN), representing 63 Centers of Excellence and 11 Affiliates in 35 countries comprising foremost experts in every class of virus causing disease in humans, and the Institut de Recherche en SantĂ©, de Surveillance EpidĂ©miologique et de Formation , or the IRESSEF, announced the addition of…

Read More

Does COVID-19 Curb or Promote the Progression of Cancer?

By vgn1 | July 2, 2021 | Comments Off on Does COVID-19 Curb or Promote the Progression of Cancer?

Does COVID-19 Curb or Promote the Progression of Cancer? July 2, 2021 One of the many questions about the long-term implications of COVID-19 is whether there might be some positive or negative consequences on cancer. The inflammatory milieu elicited by infection with SARS-CoV-2 might elicit pro-cancer effects as well as COVID-related immune-deficiency or increase DNA…

Read More